Evidence map›Paper›PMID 26888560›Full record

ReviewClinical science (London, England : 1979)2016

NOX2-dependent regulation of inflammation.

Kelly L Singel, Brahm H Segal

Abstract readReview
In one paragraph

Review in Clinical science (London, England : 1979), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 128 papers.

0numbers the graph read from it
0cells of the map it votes in
128citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

128 citing papers in PubMed, 200 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. NOX Family: Regulators of Reactive Oxygen Species Balance in Tumor Cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. The roles of neutrophils in cardiovascular diseases.Frontiers in cardiovascular medicine · 2025
    Review
  17. Review
  18. Review
  19. Article
  20. Article

68 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kelly L SingelDepartments of Immunology, Roswell Park Cancer Institute, Buffalo, NY 14263, U.S.A.
Brahm H SegalDepartments of Immunology, Roswell Park Cancer Institute, Buffalo, NY 14263, U.S.A. Departments of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, U.S.A. Department of Medicine, University at Buffalo School of Medicine, Buffalo, NY 14214, U.S.A. brahm.segal@roswellpark.org.
Roswell Park Comprehensive Cancer Center · US

Funding

Novel immunological biomarkers ovarian cancer prognosisR01CA188900 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MOYSICH, KIRSTEN B., SEGAL, BRAHM H. · 2015 to 2019
$3.3M
MULTIDISCIPLINARY APPROACHES TUMOR IMMUNOLOGYT32CA085183 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Scott I. Abrams · 2001 to 2026
$3.1M
Role of NADPH Oxidase in Regulating InflammationR01AI079253 · NIAID · ROSWELL PARK CANCER INSTITUTE CORP · PI SEGAL, BRAHM H. · 2009 to 2013
$2.1M
NCI NIH HHS R01 CA188900NCI NIH HHS T32 CA085183NIAID NIH HHS R01 AI079253NIAID NIH HHS R01 AI79253
6 · The paper itself

Abstract

NADPH oxidase (NOX) isoforms together have multiple functions that are important for normal physiology and have been implicated in the pathogenesis of a broad range of diseases, including atherosclerosis, cancer and neurodegenerative diseases. The phagocyte NADPH oxidase (NOX2) is critical for antimicrobial host defence. Chronic granulomatous disease (CGD) is an inherited disorder of NOX2 characterized by severe life-threatening bacterial and fungal infections and by excessive inflammation, including Crohn's-like inflammatory bowel disease (IBD). NOX2 defends against microbes through the direct antimicrobial activity of reactive oxidants and through activation of granular proteases and generation of neutrophil extracellular traps (NETs). NETosis involves the breakdown of cell membranes and extracellular release of chromatin and neutrophil granular constituents that target extracellular pathogens. Although the immediate effects of oxidant generation and NETosis are predicted to be injurious, NOX2, in several contexts, limits inflammation and injury by modulation of key signalling pathways that affect neutrophil accumulation and clearance. NOX2 also plays a role in antigen presentation and regulation of adaptive immunity. Specific NOX2-activated pathways such as nuclear factor erythroid 2-related factor 2 (Nrf2), a transcriptional factor that induces antioxidative and cytoprotective responses, may be important therapeutic targets for CGD and, more broadly, diseases associated with excessive inflammation and injury.

Indexed as

Signal TransductionAdaptive ImmunityAnimalsAnti-Inflammatory AgentsExtracellular TrapsHost-Pathogen InteractionsHumansInflammationMacrophagesMembrane GlycoproteinsNADPH Oxidase 2NADPH OxidasesNeutrophil InfiltrationNeutrophilsOxidative StressReactive Oxygen SpeciesAnti-Inflammatory AgentsCYBB protein, humanMembrane GlycoproteinsNADPH Oxidase 2NADPH OxidasesReactive Oxygen Specieshost defenceimmune cellsimmunologyinflammationNADPH oxidaseNADPH oxidase.NOX2

Identifiers

PMID26888560
PMCPMC5513728
OpenAlexW2307457067

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.